Startseite Diabetes
Artikel Öffentlich zugänglich

Diabetes

Veröffentlicht/Copyright: 20. Mai 2015
Veröffentlichen auch Sie bei De Gruyter Brill

Published Online: 2015-5-20
Published in Print: 2015-6-1

© 2015 by Walter de Gruyter Berlin/Boston

Artikel in diesem Heft

  1. Masthead
  2. Committees
  3. Contents
  4. Plenary Lecture Abstracts
  5. Symposium Abstracts
  6. Oral Communications Abstracts
  7. Industry Sponsored Workshop Abstract
  8. Advanced technologies, new biomarker discovery, microparticles, exosomes...
  9. Analytical technologies: flow cytometry, mass spectrometry, multiplexed analysis, metabolome analysis...
  10. Atherosclerosis, lipids and lipoproteins
  11. Autoimmune diseases, autoimmunity, allergy
  12. Biology of blood cancers
  13. Biology of extreme ages (pediatric and geriatric laboratory medicine)
  14. Biology of solid tumors
  15. Bone metabolism, osteoporosis
  16. Cardiac markers
  17. Critical care, emergency medicine, blood gases, POCT
  18. Data generation, Bioinformatics, information technology, big data
  19. Distance education, e-learning, education and training
  20. Evidence-based medicine, Lab medicine practice guidelines, decision making
  21. Inherited disorders, metabolic disorders, rare diseases
  22. Diabetes
  23. Endocrinology
  24. Nutrition, vitamins and trace elements
  25. Pharmacogenetics, pharmacogenomics, personalized medicine
  26. Prenatal and postnatal testing
  27. Genetic testing, epigenetics, molecular diagnostics
  28. Haematology
  29. Inflammation
  30. Quality assessment, laboratory errors, patient safety, ethics
  31. Kidney diseases
  32. Laboratory management, accreditation in laboratory medicine
  33. Patient management, biological sample management
  34. Reference ranges, standardization and decision levels
  35. Vascular biology, endothelium, haemostasis, cardiovascular diseases
  36. Liver, pancreas, gastrointestinal diseases, microbiome
  37. Microbiology, infectious diseases
  38. Neurological/neurodegenerative diseases
  39. Obesity, metabolic syndrome
  40. Oxidative stress
  41. Toxicology, therapeutic drug monitoring, drug addiction
Heruntergeladen am 16.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2015-5018/html
Button zum nach oben scrollen